PHLDA2 expression and promoter methylation in placental trophoblasts: Associations with preeclampsia development
Authors:
Open Access
- 1 July 2025
- journal article
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 64 (4) , 662-670
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515220121)
This publication has 36 references indexed in Scilit:
- RhoGDI1 interacts with PHLDA2, suppresses the proliferation, migration, and invasion of trophoblast cells, and participates in the pathogenesis of preeclampsiaHuman Cell, 2022
- Assessment of practice and barriers of oxygen therapy in critically ill patients among nurses: A survey from University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia, 2021Annals of Medicine & Surgery, 2022
- Preeclampsia and eclampsia: the conceptual evolution of a syndromeAmerican Journal of Obstetrics and Gynecology, 2022
- The etiology of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2022
- The placenta and preeclampsia: villain or victim?American Journal of Obstetrics and Gynecology, 2022
- Inhibition of PHLDA2 transcription by DNA methylation and YY1 in goat placentaGene, 2020
- Decreased expression of fibroblast growth factor 13 in early-onset preeclampsia is associated with the increased trophoblast permeabilityPlacenta, 2018
- Negative uterine asynchrony retards early equine conceptus development and upregulation of placental imprinted genesPlacenta, 2017
- Hypoxia-inducible microRNA-218 inhibits trophoblast invasion by targeting LASP1: Implications for preeclampsia developmentThe International Journal of Biochemistry & Cell Biology, 2017
- The significance of elevated placental PHLDA2 in human growth restricted pregnanciesPlacenta, 2014